New York - Paul Hastings LLP, a leading global law firm, announced today that the firm represented GE Medical Systems Information Technologies, Inc. (“GE Info Tech”), a wholly owned subsidiary of General Electric Company, in an underwritten secondary public offering of common stock of NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services. In connection with the offering, GE Info Tech sold 10,835,145 shares of NeoGenomics’ common stock raising gross proceeds of approximately $130 million.
Securities & Capital Markets partner Yariv Katz led the Paul Hastings team, which also included partner Stephen Cooke and associate Shai Vander.
At Paul Hastings, our purpose is clear — to help our clients and people navigate new paths to growth. With a strong presence throughout Asia, Europe, Latin America, and the U.S., Paul Hastings is recognized as one of the world’s most innovative global law firms.